TetRS is a rapid genotyping test that identifies key mutations in brain tumors using cerebrospinal fluid samples obtained through lumbar puncture.

A test that looks for genetic hallmarks of brain cancers in samples of cerebrospinal fluid can decrease the time to diagnosis and eliminate the need...

USask spearheads cutting-edge research. SASKATOON — University of Saskatchewan (USask) researchers Dr. Changiz Taghibiglou (PhD) and Dr. Sara...

Researchers at Mayo Clinic and their collaborators have made a significant discovery in understanding Alzheimer’s disease by identifying unique...

Researchers have discovered metabolic markers that forecast cancer patients' immunotherapy responses and survival outcomes, highlighting the...

An artificial intelligence-powered method for detecting tumour DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a...

Trying to figure out whether someone has Alzheimer's disease usually involves a battery of assessments-;interviews, brain imaging, blood and...

Researchers at the University of Gothenburg have developed an AI model that increases the potential for detecting cancer through sugar analyses

Researchers performed a case-control study to compare metabolic changes between individuals homozygous for a loss-of-function genetic variation in...

The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell...